Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard E Greenberg

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|March 29, 2007
American College of Clinical Pharmacology position statement on the use of microdosing in the drug development processJoseph S Bertino, Howard E Greenberg, Michael D Reed, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Risk Assessment for First-in-Human StudiesMattheus Thijs van Iersel, Howard E Greenberg, Mary L Westrick
Clinical Ophthalmology (Auckland, N.Z.)|June 6, 2017
Comprehensive review of visual defects reported with topiramateLisa Ford, Jeffrey L Goldberg, Fred Selan, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum SessionGary L Steinman, William B Smith, Mary L Westrick, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Safety in FIH Trials: A Summary of the Symposium "Fatal Drug Trial in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost"Howard E Greenberg, Mattheus Thijs van Iersel, Mary L Westrick, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 19, 2016
Is uveitis associated with topiramate use? A cumulative reviewJeffrey L Goldberg, Amy G Lau, Bo Fan, et al.
Journal of Clinical Pharmacology|March 31, 2007
The pharmacokinetics of taurolidine metabolites in healthy volunteersLi Gong, Howard E Greenberg, James L Perhach, et al.
Journal of Clinical Pharmacology|February 27, 2007
Human pharmacokinetics and interconversion of enantiomers of MK-0767, a dual PPARalpha/gamma agonistRonda K Rippley, Kerri X Yan, Natalie D Matthews, et al.
Journal of Clinical Pharmacology|October 1, 2003
Effect of mibefradil on CYP3A4 in vivoMaria L Veronese, Lisa P Gillen, Ellen P Dorval, et al.
Therapeutic Drug Monitoring|July 9, 2014
Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotypingJoanna C Masters, Denise M Harano, Howard E Greenberg, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|March 29, 2007
American College of Clinical Pharmacology position statement on the use of microdosing in the drug development processJoseph S Bertino, Howard E Greenberg, Michael D Reed, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Risk Assessment for First-in-Human StudiesMattheus Thijs van Iersel, Howard E Greenberg, Mary L Westrick
Clinical Ophthalmology (Auckland, N.Z.)|June 6, 2017
Comprehensive review of visual defects reported with topiramateLisa Ford, Jeffrey L Goldberg, Fred Selan, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum SessionGary L Steinman, William B Smith, Mary L Westrick, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Safety in FIH Trials: A Summary of the Symposium "Fatal Drug Trial in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost"Howard E Greenberg, Mattheus Thijs van Iersel, Mary L Westrick, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 19, 2016
Is uveitis associated with topiramate use? A cumulative reviewJeffrey L Goldberg, Amy G Lau, Bo Fan, et al.
Journal of Clinical Pharmacology|March 31, 2007
The pharmacokinetics of taurolidine metabolites in healthy volunteersLi Gong, Howard E Greenberg, James L Perhach, et al.
Journal of Clinical Pharmacology|February 27, 2007
Human pharmacokinetics and interconversion of enantiomers of MK-0767, a dual PPARalpha/gamma agonistRonda K Rippley, Kerri X Yan, Natalie D Matthews, et al.
Journal of Clinical Pharmacology|October 1, 2003
Effect of mibefradil on CYP3A4 in vivoMaria L Veronese, Lisa P Gillen, Ellen P Dorval, et al.
Therapeutic Drug Monitoring|July 9, 2014
Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotypingJoanna C Masters, Denise M Harano, Howard E Greenberg, et al.
Pageof 3